QualityStocksNewsBreaks – Endonovo Therapeutics Inc. (ENDV) Announces Reverse Stock Split
Endonovo Therapeutics (OTCQB: ENDV), a commercial-stage developer of noninvasive Electroceutical(R) therapeutic devices, on Thursday announced its filing of a preliminary information statement with respect to a proposed reverse stock split of its common stock at a ratio of between 1 for 100 and 1-for-1,000. According to the update, the proposed reverse stock split effectiveness is contingent upon final SEC clearance of the Information Statement, mailing of the statement and a twenty-day waiting period, Endonovo’s sole director’s decision as to the final ratio of the reverse stock split, filing of a certificate of amendment to the company’s certificate of incorporation, and…